Caprolisin may be available in the countries listed below.
Ingredient matches for Caprolisin
Aminocaproic Acid is reported as an ingredient of Caprolisin in the following countries:
- Bangladesh
International Drug Name Search
Caprolisin may be available in the countries listed below.
Aminocaproic Acid is reported as an ingredient of Caprolisin in the following countries:
International Drug Name Search
BBDent may be available in the countries listed below.
Benzocaine is reported as an ingredient of BBDent in the following countries:
International Drug Name Search
Kemicetin may be available in the countries listed below.
Chloramphenicol is reported as an ingredient of Kemicetin in the following countries:
International Drug Name Search
Glimaryl may be available in the countries listed below.
Glimepiride is reported as an ingredient of Glimaryl in the following countries:
International Drug Name Search
Mirtazapina Sandoz may be available in the countries listed below.
Mirtazapine is reported as an ingredient of Mirtazapina Sandoz in the following countries:
International Drug Name Search
Generic Name: carteolol ophthalmic (kar TEE oh lol off THAL mik)
Brand Names: Ocupress
Carteolol is a beta-blocker that reduces pressure inside the eye.
Carteolol ophthalmic may also be used for other purposes not listed in this medication guide.
Before using this medication, tell your doctor if you have breathing problems such as bronchitis or emphysema, a history of heart disease or congestive heart failure, diabetes, history of stroke, blood clot, or circulation problems, a thyroid disorder, or a muscle disorder such as myasthenia gravis.
Carteolol ophthalmic is sometimes given together with other eye medications to treat glaucoma. Do not use any other eye medication unless your doctor has prescribed it for you. If you use another eye medication, use it at least 10 minutes before or after using carteolol ophthalmic. Do not use the medications at the same time.
asthma, or severe chronic obstructive pulmonary disease (COPD);
slow heartbeats; or
a heart condition called "AV block."
If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:
breathing problems such as bronchitis or emphysema;
a history of heart disease or congestive heart failure;
diabetes;
history of stroke, blood clot, or circulation problems;
a thyroid disorder; or
a muscle disorder such as myasthenia gravis.
Use carteolol ophthalmic exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor. Follow the instructions on your prescription label.
To apply the eye drops:
Tilt your head back slightly and pull down your lower eyelid. Hold the dropper above the eye with the dropper tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.
Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct. If you use more than one drop in the same eye, wait about 5 minutes before putting in the next drop.
Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.
Do not use the eye drops if the liquid has changed colors or has particles in it. Call your doctor for a new prescription.
Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.
Overdose symptoms may include slow heart rate, wheezing, feeling short of breath, swelling, rapid weight gain, or fainting.
Carteolol ophthalmic is sometimes given together with other eye medications to treat glaucoma. Do not use any other eye medication unless your doctor has prescribed it for you. If you use another eye medication, use it at least 10 minutes before or after using carteolol ophthalmic. Do not use the medications at the same time.
severe swelling, itching, burning, redness, pain, or discomfort in or around your eye;
drainage, crusting, or oozing of your eyes or eyelids;
bronchospasm (wheezing, chest tightness, trouble breathing);
slow heart rate, weak pulse, fainting, slow breathing (breathing may stop);
fast or pounding heartbeats;
feeling short of breath, even with mild exertion; or
swelling, rapid weight gain.
Less serious side effects may include:
mild burning, stinging, itching, or watering of your eyes;
blurred or cloudy vision;
mildly swollen or puffy eyes;
increased sensitivity of your eyes to light;
trouble seeing at night;
droopy eyelids;
headache, dizziness, depression ;
muscle weakness;
sleep problems (insomnia);
stuffy nose; or
nausea, altered sense of taste.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Before using carteolol ophthalmic, tell your doctor if you are using any of the following drugs:
oral carteolol (Blocadren);
digoxin (digitalis, Lanoxin);
reserpine;
insulin or diabetes medications you take by mouth;
any other beta-blocker such as atenolol (Tenormin), bisoprolol (Zebeta), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), timolol (Blocadren), and others;
a calcium channel blocker such as amlodipine (Norvasc), diltiazem (Tiazac, Cartia, Cardizem), felodipine (Plendil), nifedipine (Nifedical, Procardia, Adalat), verapamil (Calan, Covera, Isoptin, Verelan); or
medicines to treat psychiatric disorders, such as chlorpromazine (Thorazine), haloperidol (Haldol), mesoridazine (Serentil), or thioridazine (Mellaril).
This list is not complete and there may be other drugs that can interact with carteolol ophthalmic. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
See also: Ocupress side effects (in more detail)
AK-Fluor is a brand name of fluorescein, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of AK-Fluor available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of AK-Fluor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with AK-Fluor.
Terbinafine Zydus may be available in the countries listed below.
Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafine Zydus in the following countries:
International Drug Name Search
Enalapril HCT-1a Pharma may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril HCT-1a Pharma in the following countries:
Hydrochlorothiazide is reported as an ingredient of Enalapril HCT-1a Pharma in the following countries:
International Drug Name Search
Amisol may be available in the countries listed below.
Clobetasol is reported as an ingredient of Amisol in the following countries:
International Drug Name Search
Topiramat-Actavis may be available in the countries listed below.
Topiramate is reported as an ingredient of Topiramat-Actavis in the following countries:
International Drug Name Search